FGF19–FGFR4 Signaling in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the sixth most common type of cancer, with an increasing mortality rate. Aberrant expression of fibroblast growth factor 19–fibroblast growth factor receptor 4 (FGF19–FGFR4) is reported to be an oncogenic-driver pathway for HCC patients. Thus, the FGF19–FGFR4 signal...

Descripción completa

Detalles Bibliográficos
Autores principales: Raja, Aroosha, Park, Inkeun, Haq, Farhan, Ahn, Sung-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627123/
https://www.ncbi.nlm.nih.gov/pubmed/31167419
http://dx.doi.org/10.3390/cells8060536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627123/
https://www.ncbi.nlm.nih.gov/pubmed/31167419
http://dx.doi.org/10.3390/cells8060536

Ejemplares similares